The secondary objective is to communicate

Prevention of osteoporosis. Previous studies have shown that soy isoflavones

can prevent osteoporosis and reduce the symptoms of menopause. But

there is no scientific evidence to document their long-term safety and efficacy in preventing

osteoporosis. The main goal of $ 4. 5000000 project called prevention of osteoporosis

Use soy or OPUS whether isoflavones work, whether they are safe

for a long time and the optimal dosage. The secondary aim chat

results in clear terms and medical facilities

and consumers. Four healthy, in postmenopausal women will be enrolled at three sites in the U.S. two years of observation, a randomized, double-blind, placebo-controlled study >>. << One-third of women receiving placebo, one third will receive

isoflavones supplements to 80 mg / day, and the remaining third will be

to receive supplements of 120 mg isoflavones / day.

For security control, mammograms, and women-examination, pap smear, stool

Huayak tests and clinical chemistry blood will not. To control

efficiency, total body and regional bone content and density, and

as biochemical markers of bone will be measured. To determine the optimal dose

changes in bone measurements will be related to blood concentrations of isoflavones. Industrial partners are buy lasix online Acatris Holding BV, which provided SoyLife

isoflavones materials; EB Healthpharma BV, which is manufactured and packaged

isoflavones and placebo tablets; Swanson health products that provide

multivitamins, and Source Naturals, which provide calcium. Several states, several institutional investigation ensures that the results of research

represent postmenopausal women in the U.S. population. Increasing awareness of osteoporosis and translation and dissemination of scientific findings

, health professionals and consumers will improve the knowledge of how the

to prevent this common, costly, debilitating disease. . << >>